Milli-Mark® Anti-Integrin β1 (CD29)-FITC conjugate Antibody, clone MB1.2

Description

• General description: Integrin beta 1, also known as CD29, is a 130 kDa transmembrane glycoprotein that forms noncovalent complexes with various Integrin alpha subunits (including alpha 1, alpha 2, alpha 3, alpha 4, alpha 5, and alpha 6, also known as CD49a, CD49b, CD49c, CD49d, CD49e, and CD49f, respectively) to form the functional receptors that bind to specific extracellular matrix proteins. Integrin receptors are involved in the regulation of a variety of important biological functions, including embryonic development, wound repair, hemostasis, and prevention of programmed cell death. They are also implicated in abnormal pathological states such as tumor directed angiogenesis, tumor cell growth, and metastasis. Interactions between integrins and the extracellular matrix lead to activation of signal transduction pathways and regulation of gene expression.
• Specificity: Antibody recognizes integrin β1.
• Application: Research CategoryCell Structure
• Quality: Evaluated by flow cytometry using NIH/3T3
• Target description: 88 kDa Calculated
• Physical form: Protein A purified
• Storage and Stability: Maintain refrigerated at 2-8°C protected from light for up to 6 months from date of receipt.
• Analysis Note: ControlNIH/3T3 cells
• Legal Information: MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.